Date published: 2026-6-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

Amphiphysin Inhibitors

Amphiphysin inhibitors constitute a diverse class of chemical compounds that primarily target the function of amphiphysins, a family of endocytic proteins involved in clathrin-mediated vesicle formation and intracellular trafficking processes. These inhibitors are designed to modulate the interaction between amphiphysins and various binding partners critical for endocytosis, thus affecting cellular processes that rely on this fundamental mechanism. amphiphysin inhibitors encompasses a range of compounds with distinct mechanisms of action, all aimed at perturbing the intricate orchestration of vesicle formation and membrane trafficking. These inhibitors often interfere with protein-protein interactions involving amphiphysins, disrupting their ability to interact with key partners such as endophilins, dynamin, and clathrin. By blocking these interactions, amphiphysin inhibitors impede the assembly of clathrin-coated pits, structures that play a central role in clathrin-mediated endocytosis. Some inhibitors achieve this disruption by directly binding to amphiphysins, thereby preventing their engagement with other proteins. Alternatively, certain amphiphysin inhibitors work indirectly by modulating the levels of phosphoinositides or lipid molecules that participate in the recruitment of amphiphysins to the cellular membrane. This class of inhibitors has proven instrumental in elucidating the intricate machinery of endocytosis, shedding light on the nuanced interplay of proteins and lipids that underlie this fundamental cellular process. In conclusion, amphiphysin inhibitors represent a category of compounds intricately designed to interfere with the interactions and functions of amphiphysins within the context of clathrin-mediated endocytosis. Their mechanisms of action are multifaceted, involving direct binding to amphiphysins, disruption of protein-protein interactions, and modulation of lipid signaling pathways. These inhibitors have contributed significantly to our understanding of the molecular intricacies governing endocytosis, offering valuable tools for deciphering the cellular machinery responsible for vesicle formation and intracellular trafficking.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Chlorpromazine

50-53-3sc-357313
sc-357313A
5 g
25 g
$61.00
$110.00
21
(1)

Chlorpromazine, a cationic amphiphilic drug, can interfere with clathrin-mediated endocytosis and vesicle formation by affecting membrane properties and dynamics.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Dynasore inhibits amphiphysin I by blocking the GTPase activity of dynamin, preventing clathrin-mediated endocytosis and vesicle formation.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Brefeldin A disrupts vesicular trafficking and indirectly affects amphiphysin I-mediated processes by inhibiting the transport of proteins between the endoplasmic reticulum and Golgi.